Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Alzheimer's disease in humans and other animals: A consequence of postreproductive life span and longevity rather than aging.

Gunn-Moore D, Kaidanovich-Beilin O, Gallego Iradi MC, Gunn-Moore F, Lovestone S.

Alzheimers Dement. 2018 Feb;14(2):195-204. doi: 10.1016/j.jalz.2017.08.014. Epub 2017 Sep 30.

PMID:
28972881
2.

The putative impact of metabolic health on default mode network activity and functional connectivity in neuropsychiatric disorders.

Cha DS, De Michele F, Soczynska JK, Woldeyohannes HO, Kaidanovich-Beilin O, Carvalho AF, Malhi GS, Patel H, Sim K, Brietzke E, Mansur R, Dunlop KA, Alsuwaidan M, Baskaran A, Fagiolini A, Reznikov R, Kudlow PA, McIntyre RS.

CNS Neurol Disord Drug Targets. 2014;13(10):1750-8. Review.

PMID:
25470392
3.

Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.

McIntyre RS, Cha DS, Jerrell JM, Swardfager W, Kim RD, Costa LG, Baskaran A, Soczynska JK, Woldeyohannes HO, Mansur RB, Brietzke E, Powell AM, Gallaugher A, Kudlow P, Kaidanovich-Beilin O, Alsuwaidan M.

Bipolar Disord. 2014 Aug;16(5):531-47. doi: 10.1111/bdi.12162. Epub 2013 Dec 16. Review.

PMID:
24330342
4.

Obesity and mental illness: implications for cognitive functioning.

McIntyre RS, Cha DS, Jerrell JM, Soczynska JK, Woldeyohannes HO, Taylor V, Kaidanovich-Beilin O, Alsuwaidan M, Ahmed AT.

Adv Ther. 2013 Jun;30(6):577-88. doi: 10.1007/s12325-013-0040-5. Epub 2013 Jul 3. Review.

PMID:
23839214
5.

Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.

Beurel E, Kaidanovich-Beilin O, Yeh WI, Song L, Palomo V, Michalek SM, Woodgett JR, Harrington LE, Eldar-Finkelman H, Martinez A, Jope RS.

J Immunol. 2013 May 15;190(10):5000-11. doi: 10.4049/jimmunol.1203057. Epub 2013 Apr 19.

6.

Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance.

Gulen MF, Bulek K, Xiao H, Yu M, Gao J, Sun L, Beurel E, Kaidanovich-Beilin O, Fox PL, DiCorleto PE, Wang JA, Qin J, Wald DN, Woodgett JR, Jope RS, Carman J, Dongre A, Li X.

Immunity. 2012 Nov 16;37(5):800-12. doi: 10.1016/j.immuni.2012.08.019. Epub 2012 Nov 8.

7.

The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders.

McIntyre RS, Powell AM, Kaidanovich-Beilin O, Soczynska JK, Alsuwaidan M, Woldeyohannes HO, Kim AS, Gallaugher LA.

Behav Brain Res. 2013 Jan 15;237:164-71. doi: 10.1016/j.bbr.2012.09.021. Epub 2012 Sep 20. Review.

PMID:
23000536
8.

Crosstalk between metabolic and neuropsychiatric disorders.

Kaidanovich-Beilin O, Cha DS, McIntyre RS.

F1000 Biol Rep. 2012;4:14. doi: 10.3410/B4-14. Epub 2012 Jul 2.

9.

Neurological functions of the masterswitch protein kinase - gsk-3.

Kaidanovich-Beilin O, Beaulieu JM, Jope RS, Woodgett JR.

Front Mol Neurosci. 2012 Apr 9;5:48. doi: 10.3389/fnmol.2012.00048. eCollection 2012. No abstract available.

10.

GSK-3: Functional Insights from Cell Biology and Animal Models.

Kaidanovich-Beilin O, Woodgett JR.

Front Mol Neurosci. 2011 Nov 16;4:40. doi: 10.3389/fnmol.2011.00040. eCollection 2011.

11.

Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.

Lee FH, Kaidanovich-Beilin O, Roder JC, Woodgett JR, Wong AH.

Schizophr Res. 2011 Jun;129(1):74-9. doi: 10.1016/j.schres.2011.03.032. Epub 2011 Apr 17.

PMID:
21498050
12.

Selective loss of glycogen synthase kinase-3α in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation.

Alon LT, Pietrokovski S, Barkan S, Avrahami L, Kaidanovich-Beilin O, Woodgett JR, Barnea A, Eldar-Finkelman H.

FEBS Lett. 2011 Apr 20;585(8):1158-62. doi: 10.1016/j.febslet.2011.03.025. Epub 2011 Mar 21.

13.

Assessment of social interaction behaviors.

Kaidanovich-Beilin O, Lipina T, Vukobradovic I, Roder J, Woodgett JR.

J Vis Exp. 2011 Feb 25;(48). pii: 2473. doi: 10.3791/2473.

14.

Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.

Lipina TV, Kaidanovich-Beilin O, Patel S, Wang M, Clapcote SJ, Liu F, Woodgett JR, Roder JC.

Synapse. 2011 Mar;65(3):234-48. doi: 10.1002/syn.20839.

15.

Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.

Kaidanovich-Beilin O, Lipina TV, Takao K, van Eede M, Hattori S, Laliberté C, Khan M, Okamoto K, Chambers JW, Fletcher PJ, MacAulay K, Doble BW, Henkelman M, Miyakawa T, Roder J, Woodgett JR.

Mol Brain. 2009 Nov 19;2:35. doi: 10.1186/1756-6606-2-35.

16.

Peptides targeting protein kinases: strategies and implications.

Kaidanovich-Beilin O, Eldar-Finkelman H.

Physiology (Bethesda). 2006 Dec;21:411-8. Review.

17.
18.

Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.

Kirshenboim N, Plotkin B, Shlomo SB, Kaidanovich-Beilin O, Eldar-Finkelman H.

J Mol Neurosci. 2004;24(2):237-45.

PMID:
15456937
19.

Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.

Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H.

Biol Psychiatry. 2004 Apr 15;55(8):781-4.

PMID:
15050857

Supplemental Content

Loading ...
Support Center